India will produce more than 100 million doses a year of the vaccine against Russia’s coronavirus disease (Covid-19) Sputnik V starting in 2021 following an agreement between Russia’s Direct Investment Fund (RDIF) and Hetero Biopharma, with headquarters in Hyderabad. Sputnik V is based on a well-studied platform of human adenoviral …
Read More »
MUMBAI: Sputnik V Covid-19 of Russia vaccine, which reported an efficiency of more than 95%, will be twice as cheap as Pfizer and Moderna with similar positive results. Sputnik V, developed by Gamaleya Institute Y RDIF (Russian Direct Investment Fund), will be priced at less than $ 20 per person …
Read More »
NEW DELHI The Russian Direct Investment Fund (RDIF) has signed a pact with Delhi-based pharmaceutical company Mankind Pharma for the marketing and distribution of its Sputnik V vaccine, two sources with knowledge of the matter said. “It depends on how many doses you give to humanity. RDIF has deals with …
Read More »
MOSCOW: Clinical trials of the Sputnik V coronavirus vaccine will take place this month in several countries, including India, Kirill Dmitriev, executive director of the Russian Direct Investment Fund (RDIF), confirmed on Monday. Dmitriev said that clinical trials in Saudi Arabia, the United Arab Emirates (UAE), the Philippines, India and …
Read More »
MOSCOW: Clinical trials of the Sputnik V coronavirus vaccine will take place this month in several countries, including India, Kirill Dmitriev, executive director of the Russian Direct Investment Fund (RDIF), confirmed on Monday. Dmitriev said that clinical trials in Saudi Arabia, the United Arab Emirates (UAE), the Philippines, India and …
Read More »